SMMT 8-K 2026-09-29
Summit Therapeutics Inc. (SMMT) 8-K dated 2026-09-29 — accession 0001193125-26-405776.
Summit Therapeutics Inc. (SMMT) is a biotechnology company listed on US.
Summit Therapeutics Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-405776.
This 8-K covers: Material agreement (Item 1.01), Unregistered share sale (Item 3.02), Bylaws or fiscal year change (Item 5.03), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported SMMT revenue for 2024-12-31 was $0. Net income was -$221.3M. SMMT currently screens at market cap $11.46B.
Not investment advice. The SMMT SEC hub lists recent forms. The stock page is the research view.